OXB has signed an agreement with Plowshare Therapies, a biotechnology company developing gene therapies for rare genetic ...

AdvanCell, a clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer, has closed an ...

BriaCell Therapeutics Corp. has entered into a manufacturing arrangement with FUJIFILM Biotechnologies California to support ...

Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, has entered a multi-target strategic ...

Evonik has partnered with global antibody expression specialist evitria to offer a ready-to-use transient protein expression kit based on CHO cells for biopharmaceutical research and development.

EpilepsyGTx, a biotechnology company, and ClearPoint Neuro, a global therapy-enabling company offering precise navigation and ...

OneSource Specialty Pharma Limited and Formycon AG have entered a strategic manufacturing partnership for biosimilars.

Charles River Laboratories International Inc. has partnered with Arovella Therapeutics Ltd to provide Good Manufacturing ...

On "The Friday Brief," coming back from the July 4th holiday, no shortage of pharma wheelings and dealings to begin July.

Takara Bio USA, a subsidiary of Takara Bio, announced the retirement of President and Chief Executive Officer Carol Lou.

WuXi Biologics’ MFG8 drug substance manufacturing facility in Hebei, China successfully passed U.S. FDA Pre-License ...

What it takes to produce complex OSD drug products from the earliest stages of development to rapid, low-risk tech transfer ...